Cite

1. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 2016 Sep;4(9):e609-16.10.1016/S2214-109X(16)30143-7Search in Google Scholar

2. Cyranka M, Kapka-Skrzypczak L, Rzeski W. Chemoprewencja nowotworów – perspektywy zastosowania w profilaktyce i terapii. Zdr Publ 2009;119(2):223-7.Search in Google Scholar

3. Szwejda-Grzybowska J. Antykancerogenne składniki warzyw kapustnych i ich znaczenie w profilaktyce chorób nowotworowych. Bromat Chem Toksykol 2011;4:1039-46.Search in Google Scholar

4. Al-Gendy AA, Nematallah KA, Zaghloul SS, Ayoub NA. Glucosinolate profile, volatile constituents, antimicrobial, and cytotoxic activities of Lobularia libyca. Pharm Biol 2016;15(12):3257-63.10.1080/13880209.2016.122314627597660Search in Google Scholar

5. Wideł MS, Wideł M. Mechanizmy przerzutowania i molekularne mark-ery progresji nowotworów złośliwych. I. Rak jelita grubego. Post Hig 2006;60:453-70.Search in Google Scholar

6. Śmiechowska A, Bartoszek A, Namieśnik J. Przeciwrakotwórcze właściwości glukozynolanów zawartych w kapuście (Brassica oleracea var. capitata) oraz produktów ich rozpadu. Post Hig 2008;62:125-40.Search in Google Scholar

7. Walczak K, Marciniak S, Rajtar G. Chemoprewencja nowotworów – wybrane molekularne mechanizmy działania. Post Hig 2017;71:149-61.Search in Google Scholar

8. Novio S, Cartea ME, Soengas P, Freire-Garabal M, Núñez-Iglesias MJ. Effects of Brassicaceae isothiocyanates of prostate cancer. Molecules 2016;21(5). pii: E626.10.3390/molecules21050626627289827187332Search in Google Scholar

9. Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev 2005;14(9):2093-7.10.1158/1055-9965.EPI-05-022616172215Search in Google Scholar

10. Malczyk E, Majkrzak Ż. Żywieniowe czynniki rozwoju raka piersi. Probl Hig Epidemiol 2015;96(1):67-76.Search in Google Scholar

11. Haschem FA., Motawea A, El-Shabrawy AE, Shaker K, El-Sherbini S. Myrosinase hydrolysates of Brassica olareceae L. var. italica reduce the risk of colon cancer. Phytother Res 2012;26(5):743-7.Search in Google Scholar

12. Chen YJ, Wallig MA, Jeffery EH. Dietary broccoli lessens development of fatty liver and liver cancer in mice given diethylnitrosamine and fed a Western or control diet. J Nutr 2016;146(3):542-50.10.3945/jn.115.228148476348826865652Search in Google Scholar

13. Tomczyk J, Olejnik A. Sulforafan – potencjalny czynnik w prewencji i terapii chorób nowotworowych. Post Hig 2010;64:590-603.Search in Google Scholar

14. Jakubíková J, Sedlák J, Mithen R, Bao Y. Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem Pharmacol 2005;69(11):1543-52.10.1016/j.bcp.2005.03.01515896333Search in Google Scholar

15. Pappa G, Bartsch H, Gerhäuser C. Biphasic modulation of cell proliferation by sulforaphane at physiologically relevant exposure times in a human colon cancer cell line. Mol Nutr Food Res 2007;51(8):977-84.10.1002/mnfr.20070011517628879Search in Google Scholar

16. Park SY, Kim GY, Bae SJ, Yoo YH, Choi YH. Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol Rep 2007;18(1):181-7.10.3892/or.18.1.181Search in Google Scholar

17. Wu J, Han J, Hou B, Deng C, Wu H, Shen L. Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway. Oncol Rep 2016;35(5):2977-83.10.3892/or.2016.463826935987Search in Google Scholar

18. Ullah MF. Sulforaphane (SFN): an isothiocyanate in a cancer chemoprevention paradigm. Medicines (Basel) 2015;2(3):141-56.10.3390/medicines2030141545621528930206Search in Google Scholar

19. Wagner AE, Boesch-Saadatmandi C, Dose J, Schultheiss G, Rimbach G. Anti-inflammatory potential of allyl-isothiocyanate – role of Nrf2, NF-κB and micro-RNA-155. J Cell Mol Med 2012;16(4):836-43.10.1111/j.1582-4934.2011.01367.x382285221692985Search in Google Scholar

20. Fuentes F, Paredes-Gonzalez X, Kong AT. Dietary glucosinolates sulforaphane, phenethyl isothiocyanate, indole-3-carbinol/3,3’-diindolyl-methane: anti-oxidative stress/inflammation, Nrf2, epigenetics/epigenomics and in vivo cancer chemopreventive efficacy. Curr Pharmacol Rep 2015;1(3):179-96.10.1007/s40495-015-0017-y459654826457242Search in Google Scholar

21. Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, et al. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: A histopathologic study of whole mount prostate specimens. Prostate 2004;60(1):25-31.10.1002/pros.2001315129426Search in Google Scholar

22. Caruso JA, Campana R, Wei C, Su CH, Hanks AM, Bornmann WG, et al. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells. Cell Cycle 2014;13(16):2587-99.10.4161/15384101.2015.942210461445125486199Search in Google Scholar

23. Dziurzyński S, Kultys J. Choroba wrzodowa wczoraj i dziś. Przegląd Medyczny Uniwersytetu Rzeszowskiego 2008;1:91-7.Search in Google Scholar

24. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene induced stomach tumors. Proc Natl Acad Sci U S A 2002;99(11):7610-5.10.1073/pnas.11220309912429912032331Search in Google Scholar

25. Sotelo T, Lema M, Soengas P, Cartea ME, Velasco P. In vitro activity of glucosinolates and their degradation products against brassica-pathogenic bacteria and fungi. Appl Environ Microbiol 2015;81(1):432-40.10.1128/AEM.03142-14427270525362058Search in Google Scholar

26. Piekarska A, Bartoszek A, Namieśnik J. Biofumigacja jako alternatywna metoda ochrony roślin. Ecological Chemistry and Engineering S 2010;17(4):527-47.Search in Google Scholar

eISSN:
2719-6313
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Basic Medical Science, other, Clinical Medicine, Surgery, Public Health